1. Home
  2. CYTK vs ENPH Comparison

CYTK vs ENPH Comparison

Compare CYTK & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ENPH
  • Stock Information
  • Founded
  • CYTK 1997
  • ENPH 2006
  • Country
  • CYTK United States
  • ENPH United States
  • Employees
  • CYTK N/A
  • ENPH N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ENPH Semiconductors
  • Sector
  • CYTK Health Care
  • ENPH Technology
  • Exchange
  • CYTK Nasdaq
  • ENPH Nasdaq
  • Market Cap
  • CYTK 4.4B
  • ENPH 4.2B
  • IPO Year
  • CYTK 2004
  • ENPH 2012
  • Fundamental
  • Price
  • CYTK $38.62
  • ENPH $35.43
  • Analyst Decision
  • CYTK Buy
  • ENPH Hold
  • Analyst Count
  • CYTK 13
  • ENPH 33
  • Target Price
  • CYTK $71.58
  • ENPH $59.65
  • AVG Volume (30 Days)
  • CYTK 1.4M
  • ENPH 9.4M
  • Earning Date
  • CYTK 08-07-2025
  • ENPH 07-22-2025
  • Dividend Yield
  • CYTK N/A
  • ENPH N/A
  • EPS Growth
  • CYTK N/A
  • ENPH 37.10
  • EPS
  • CYTK N/A
  • ENPH 1.28
  • Revenue
  • CYTK $85,738,000.00
  • ENPH $1,482,823,000.00
  • Revenue This Year
  • CYTK $27.08
  • ENPH $12.75
  • Revenue Next Year
  • CYTK $652.09
  • ENPH N/A
  • P/E Ratio
  • CYTK N/A
  • ENPH $25.25
  • Revenue Growth
  • CYTK 2635.74
  • ENPH 4.39
  • 52 Week Low
  • CYTK $29.31
  • ENPH $29.89
  • 52 Week High
  • CYTK $59.39
  • ENPH $130.08
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 60.89
  • ENPH 42.30
  • Support Level
  • CYTK $32.89
  • ENPH $31.30
  • Resistance Level
  • CYTK $36.79
  • ENPH $34.77
  • Average True Range (ATR)
  • CYTK 1.73
  • ENPH 1.50
  • MACD
  • CYTK 0.15
  • ENPH 0.29
  • Stochastic Oscillator
  • CYTK 91.77
  • ENPH 58.85

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ENPH Enphase Energy Inc.

Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.

Share on Social Networks: